PT - JOURNAL ARTICLE AU - Tomori, Damilola Victoria AU - Rübsamen, Nicole AU - Berger, Tom AU - Scholz, Stefan AU - Walde, Jasmin AU - Wittenberg, Ian AU - Lange, Berit AU - Mikolajczyk, Rafael AU - Jaeger, Veronika K AU - Karch, André TI - Individual social contact data reflected SARS-CoV-2 transmission dynamics during the first wave in Germany better than population mobility data – an analysis based on the COVIMOD study AID - 10.1101/2021.03.24.21254194 DP - 2021 Jan 01 TA - medRxiv PG - 2021.03.24.21254194 4099 - http://medrxiv.org/content/early/2021/03/26/2021.03.24.21254194.short 4100 - http://medrxiv.org/content/early/2021/03/26/2021.03.24.21254194.full AB - Background The effect of contact reduction measures on infectious disease transmission can only be assessed indirectly and with considerable delay. However, individual social contact data and population mobility data can offer near real-time proxy information.Aim To compare social contact data and population mobility data with respect to their ability to predict transmission dynamics during the first wave of the SARS-CoV-2 pandemic in Germany.Methods We quantified the change in social contact patterns derived from self-reported contact survey data collected by the German COVIMOD study from 04/2020-06/2020 (compared to the pre-pandemic period), and estimated the percentage mean reduction in the effective reproduction number R(t) over time. We compared these results to the ones based on R(t) estimates from open-source mobility data and to R(t) values provided by the German Public Health Institute.Results We observed the largest reduction in social contacts (90%, compared to pre-pandemic data) in late April corresponding to the strictest contacts reduction measures. Thereafter, the reduction in contacts dropped continuously to a minimum of 73% in late June. R(t) estimates based on social contacts underestimated measured R(t) values slightly in the time of strictest contact reduction measures but predicted R(t) well thereafter. R(t) estimates based on mobility data overestimated R(t) considerably throughout the study.Conclusions R(t) prediction accuracy based on contact survey data was superior to the one based on population mobility data, indicating that measuring changes in mobility alone is not sufficient for understanding changes in transmission dynamics triggered by public health measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe survey waves of the COVIMOD study used for these analyses were funded by intramural funds from the Institute for Epidemiology and Social Medicine, University of Muenster. In general, COVIMOD is funded by intramural funds of the Institute of Epidemiology and Social Medicine, University of Muenster, and of the Institute for Medical Epidemiology Biometry, and Informatics, Martin Luther University Halle-Wittenberg, as well as by funds of the Robert Koch Institute, Berlin, the Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V. via the HZEpiAdHoc "The Helmholtz Epidemiologic Response against the COVID-19 Pandemic" project and the German Free State of Saxony via the SaxoCOV project.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:COVIMOD was approved by the ethics committee of the Medical Board Westfalen-Lippe and the University of Muenster, reference number 2020-473-f-s. Informed consent was obtained from all study participants of the COVIMOD study. The POLYMOD data collection was approved by national institutional review boards [12]. As only anonymised POLYMOD data were used in this study, institutional review was not required for reanalysis.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are available from the corresponding author upon valid scientific request.